Blueberry Therapeutics inks Series B funding
UK-based Blueberry Therapeutics, a developer of nanomedicines for difficult to treat skin and nail infections, has secured 10 million pounds in Series B funding. The investors were China Medical Venture Investment and A&B.
16 August 2018•1 min read
